New briefing provides heart failure advocates with actionable ways to improve access to best-practice care in Germany

News & Events

15 May 2023
AUTHOR: Ellen McIntosh

The latest advocacy briefing in our From guidelines to action series highlights the opportunities for heart failure advocates to improve care in Germany.

Based on extensive research and expert interviews, the briefing recommends specific actions, including:

Heart failure is more prevalent in Germany than in other European countries. There is a need to create a common national vision for heart failure – and cardiovascular health more broadly – to improve access to best-practice care, diagnosis and prevention.

This briefing is the fourth and final in our From guidelines to action series, which aims to equip national advocates with a targeted analysis of the opportunities available in their countries, along with specific actions they can take to change the narrative in their regions. All of the actions are supported by successful examples from a number of health interventions and interviews with national heart failure experts. The German briefing follows reports on France, Italy and Spain.

Download the report

Tagged:

More from News & Events

Heart failure community meets in the European Parliament to
Heart failure community meets in the European Parliament to ...
11 December 2025
At this critical juncture, as the EU drafts its Cardiovascular Health Plan, the event brought together policymakers, clinicians, patient representatives and researchers from across...
Read article
New country profile highlights urgent need for national hear
New country profile highlights urgent need for national hear...
27 November 2025
Commissioned by the Netherlands Heart Institute as an addition to the existing 'Heart failure policy and practice in Europe' series, the profile is designed to equip advocates and ...
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, Bayer and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership. EU Transparency Register ID: 223430420230-66.